HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

BIM-23244

a somatostatin receptor subtype 2- and 5-selective analog with enhanced efficacy in suppressing growth hormone (GH) from octreotide-resistant human GH-secreting adenomas
Also Known As:
BIM 23244
Networked: 3 relevant articles (1 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Culler, M D: 3 articles (10/2005 - 01/2001)
2. Saveanu, A: 2 articles (07/2005 - 01/2001)
3. Gunz, G: 2 articles (07/2005 - 01/2001)
4. Jaquet, P: 2 articles (07/2005 - 01/2001)
5. Enjalbert, A: 2 articles (07/2005 - 01/2001)
6. Dufour, H: 2 articles (07/2005 - 01/2001)
7. Scanarini, M: 1 article (10/2005)
8. degli Uberti, E C: 1 article (10/2005)
9. Bottoni, A: 1 article (10/2005)
10. Zatelli, M C: 1 article (10/2005)

Related Diseases

1. Neoplasms (Cancer)
2. Adenoma (Adenomas)

Related Drugs and Biologics

1. Octreotide (Sandostatin)
2. BIM 23268
3. Somatostatin (Somatotropin Release-Inhibiting Factor)
4. Somatostatin Receptors (Somatostatin Receptor)
5. Messenger RNA (mRNA)
6. Prolactin
7. Dopamine (Intropin)
8. BIM 23A760
9. BIM 23197
10. lanreotide (Somatuline)